Is a
Patent attributes
Patent Jurisdiction
Patent Number
Patent Inventor Names
Christopher O'Brien0
Tushar Shah0
James Zangrilli0
Date of Patent
November 14, 2017
Patent Application Number
14838503
Date Filed
August 28, 2015
Patent Citations Received
Patent Primary Examiner
Patent abstract
Disclosed herein are methods of treating moderate to severe eosinophilic asthma in a patient comprising administering a therapeutically effective dose of reslizumab to a patient whose symptoms are inadequately controlled with a current asthma therapeutic and wherein the patient's blood eosinophil levels are equal to or greater than 400/μL.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
